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1. introduction 
Leukotrienes are a new group of compounds derived 
from arachidonic acid [ 1,2], eicosapentaenoic acid 
[3] and eicosatrienoic acid [4]. Each of these acids is 
the precursor of a series of compounds, which have 
been designated alphabetically and using subscripts to 
indicate the number of double bonds [S]. Leuko- 
trienes C4 and D4 are the biologically active compo- 
nents of ‘slow-reacting substance of anaphylaxis’ 
(SRS-A [6]), a smooth muscle contracting factor first 
described in 1938 [7] and subsequently suggested to 
be an important mediator of bronchoconstriction in 
allergic asthma [8]. These leukotrienes are exceedingly 
active on guinea pig and human respiratory smooth 
muscle in vitro and in vivo [9-l 11. Leukotrienes C4 
and/or D4 formation has been demonstrated in mouse 
mastocytoma cells [ 1,2] rat basophilic Ieukemia cells 
[12-151, rat mononuclear cells (l&17] andin human 
[17,18] andguineapiglung [19]. 
A pathway for leukotriene C4 biosynthesis involv- 
ing glutathione conjugation of an epoxide derived 
from arachidonic acid [ 201, has been proposed [ 1,2]. 
The epoxide, designated leukotriene A4 [S], is unsta- 
ble [20] and has been isolated from leukocytes by 
extraction after esterification, using synthetic leuko- 
triene A4 [ 211 as a carrier [22]. A more convenient 
way of determination is based on the chemical con- 
version of leukotriene A4 to diastereoisomeric 5(S)- 
hydroxy-I Z(~~)-methoxy~,8,iO-~~~ns-l4~is~icosa- 
tetraenoic acids in acidic methanol [20]. The 12- 
methoxy compounds can be quantitatively analyzed 
by high performance liquid chromatography (HPLC) 
using prostaglandin Bz as internal reference [20]. By 
this method leukotriene A4 has now been demon- 
strated to be transiently detectable during the biosyn- 
thesis of leukotrienes C4 and Dq. 
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2. Materials and methods 
ionophore A23 187 was purchased from Calbio- 
them-Behring. Rats with tumors of basophilic leuke- 
mia were generously supplied by B. H. Leonard, ICI, 
England, RBL cells were grown in Spinner cultures 
[ 121 and mastocytoma cells were propagated as ascites 
tumors [I ]. Cells (1 O’/ml) were suspended in a phos- 
phate-buffered salt solution containing D-glucose [ 11. 
2 .I . Material for structural analyses 
Mastocytoma or basophilic leukemia cells (2.4 X IO’) 
were incubated for 30 s at 37OC with 20 FM ionophore 
A23 187 and 166 PM arachidonic acid. The reaction 
was stopped with acidic methanol [20]. After adjust- 
ing the pH to 7 with NH,OH, the solution was filtered 
and concentrated under reduced pressure. The aque- 
ous solution was acidified to pH 3, extracted with 
diethylether and the extract was purified on a column 
of SilicAR CC7 (Mallinkrodt) using diethyl ether/hex- 
ane (l/4, v/v) and ethyl acetate as eluents. The latter 
fraction was subjected to reverse-phase HPLC using a 
column (500 X 10 mm) containing C ,s Polygosil and 
methanol~water (4/l, v/v) plus 0.01% acetic acid as 
mobile phase (flow rate 4.5 ml,Jmin). The absorbance 
at 280 nm was monitored at the column effluent. 
2.2. Time course experiments 
Mastocytoma or basophilic leukemia cells (4 X 10”) 
were incubated (2 min, 37°C) with Lcysteine (10 mM) 
prior to addition of ionophore A23 187 (20 PM) and 
arachidonic acid (90 MM). Incubations were terminated 
with acidic methanol after varying lengths of time. 
The pH was adjusted to 6-6.5 with NH40H and pros- 
taglandin B2 (6 nmol) was added as an internal refer- 
ence [20]. 
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2.3. Is~Iuti~F~ of le~~~trienes 
After filtration and evaporation of the solvent, the 
remaining material was chromatographed on 10 ml 
columnsof Amberlite XAD-8 [ 11. The aqueous eluates 
were acidified and extracted with diethyl ether. These 
extracts were combined with the 80% ethanol eluates 
from XAD8 [ 11 prior to silicic acid chromatography 
[l]. Ethyl acetate, methanol/ethyl acetate (l/l, v/v) 
and methanol eluates contained dihydroxyacids plus 
12-methoxy compounds, leukotriene D4 and leuko- 
triene Cq, respectively. 
The ethyl acetate eluates were analyzed by HPLC 
on C ,8 Nucleosil (250 X 4.6 mmj using methanol/ 
water (75/25, v/v) plus 0.01% acetic acid as mobile 
phase at 1 ml/min [20]. The methanol/ethyl acetate 
(l/ 1, v/v) and the methanol eluates were fractionated 
by HPLC as above except that the mobile phase was 
metllanol~water (7/3, v/v) plus 0.1% acetic acid, 
adjusted to pH 5.4 with NH,OH. 
2.4. Analytical methods 
Ultraviolet spectra were recorded with a Cary 2 19 
spectrophotolneter. Gas~hromatography-mass pec- 
trometry (GLC-MS) was performed using an LKB 
9000 S instrument with a column containing 3% OV- 
210. Prior to analyses, samples were converted to 
methyl ester, trimethylsilyl ether derivatives [20]. 
3. Results 
Mastocytoma and basophilic leukemia cells were 
incubated under conditions leading to the generation 
of leukotrienes C4 [ 1 ] and D4 [ 121. The reactions 
were performed for varying periods of time and ter- 
minated by addition of acidic methanol [20]. Fig.1 
shows a chromatogram from a 30 s incubation with 
basophilic leukemia cells. In addition to prostaglandin 
Bz, four major components were observed. Com- 
pounds I and II had the same elution times on HPLC 
as the diastereoisomeric 5(~),12(~~)-dihydroxy-6,8, 
lo-trans-14cis eicosatetraenoic acids [23]. Similarly, 
compounds III and IV were eluted at the same posi- 
tions as the 12-U-methyl derivatives of these com- 
pounds [ZO]. The ultraviolet spectra of compounds 
I-IV were identical to those of the dihydroxy acids 
and the 12-@methyl derivatives mentioned above 
@max at 268; shoulders at 280 and 258 nm, cf. 
[20,23]) indicating the presence of all-trans conju- 
gated trienes 1231. Similar results were obtained with 
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Fig.1. Reverse phaseHPLC of 5,12dihydroxyeicosatctraenoic 
acids (I$) and Shydroxy-12-methoxyeicosatetraenoic a ids 
(IIIJV) formed by rat basophilic leukemia cells (4 X 1O8) 
during an incubation (30 s, 37°C) with ionophore A23187 
(20 PM) plus arachidonic acid (90 PM). The incubation was 
terminated by addition of 10 vol. acidic methanol to convert 
leukotriene A, to S-hydroxy-12-methoxy~,8,10,14~icosa- 
tetraenoic acids. Prostaglandin (PC) B, was added as an inter- 
nal reference, prior to purification [ 201. 
mastocytoma cells. For analyses by GLC-MS, larger 
amounts of compounds I and II (-35 nmol each) and 
III and IV (-80 nmol each) were prepared as in sec- 
tion 2 and converted to methyl ester, trimethylsilyl 
ether derivatives. These derivatives of compound I and 
II had the same C-value.(25.2) as 5,12-dihydroxy-6,8, 
10,f 4eicosatetraenoic acids from leukocytes [23] and 
the mass spectra of both coInpounds were indistin- 
guishable from those reported [23,24] for the 5,12- 
dihydroxy acids 
(Ions at m/e 494 (M): 479 (M-l 5, ‘CHa), 463 (M-3 1, 
‘OCH,), 404 (M-90, (CH,)aSiOH), 383 (M-l 11, 
CH2-CH=CH-(CH+CH& 327,317,293 
(M-1 l l-90), 282, 2,67,261,229,2 17 ((CH&Si- 
($-CII=CIi-CI-I=O-.--Si(CI~~)~), 203 ((CH3)3Si- 
0=CH-(CH2)3-COOCH,) and (M-l 11-2 X 90)), 
191,189,171,167,161,159and 129). 
Similarly, compounds III and IV had the same C-value 
(25 .I) as methyl 5-trimethylsilyloxy-12-methoxy-4,8, 
10,14~icosatetraenoates f20] and their mass spectra 
were identical 
(Ions at m/e 463 (M): 421 (M-l 5, ‘CH3), 404 (M-32. 
CH,OH), 389,373,325 (M-l 11, ‘CH,-CH=CH- 
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Fig.2. Chemical tran~ormations of Ieukotriene A, to com- 
pounds I-IV. 
(CH&CHs), 2?3 (M-l 1 l-32), 267,241,235, 
203 ((CHs)3Si-O=CH-(CH2)&OOCHs and M- 
ill-90-32) 189,171,161,159,143,133and129) 
to those reported before (201. The structures of com- 
pounds I-IV and their formation from leukotriene A4 
are shown in fig.2. 
The amounts of compounds III and IV formed, 
varied depending on the incubation time. The highest 
concentrations were observed after 15-30 s (results 
for basophilic leukemia cells are shown in fig.3; similar 
results were obtained with mastocytoma cells), The 
formation of leukotriene D4 and its 1 I-frans isomer 
by basophilic leukemia cells ([ 12,131, fig.3) and leu- 
kotriene C4 [ 1,2] and I 1 -truns leukotriene C4 [ 251 
by m~tocytoma cells was determined by HPLC and 
ultraviolet spectroscopy. The results showed that the 
formation of compounds III and IV largely preceded 
leukotriene C4 and leukotriene D4 biosynthesis. 
4. Discussion 
Mastocytoma cells [ 1,2] and rat basophilic leuke- 
mia cells [ 12,131 were used for the structural deter- 
mination of the slow-reacting substances, leukotrienes 
C4 and Dq. Based on the structures deduced a biosyn- 
thetic pathway was postulated involving an allylic 
epoxide formed from arachidonic acid (leukotriene 
A4 [5,20]) as an intermediate. The present results 
show that the proposed intermediate can be detected 
during the biosynthesis of ieukotrienes C4 and D4 in 
mastocytoma and basophilic leukemia cells. This was 
shown by conversion in methanol of the intermediate 
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Fig.3. Temporai relationship between the formation of 5- 
hydroxy-12-methoxyeicosatetraenoic acids (compounds III, 
IV) and the biosynthesis of leukotriene D, plus 1 I-fruns leu- 
kotriene D, (e-o) in basophilic leukemia cells. The exper- 
iment was performed as described in the legend to fig.1 but 
the incubation time was varied. 
to stable derivatives [20] which were unambiguously 
identified from their retention times on HPLC and 
GLC and from their ultraviolet and mass spectra. Com- 
pounds III and IV (fig.1) were thus the 12(R) and 
12(S) diastereoisomers of S(S)-hydroxy-12-methoxy- 
6,8,10-tra~l4ciseicosatetraenoic acid (fig.2). In 
addition corresponding hydrolysis products of leuko- 
triene Aq, 5@),12(R)- and 5@),12(S)-dihydroxy-6,8, 
lO-~~~~s-l4~~s~icosatetraenoic acids (compounds I 
and II, respectively, fig.1) were formed (fig.2). The 
results support the proposal that leukotriene & is an 
intermediate in the biosynthesis of leukotrienes C4 
and D4 (fig.4). Evidence suggesting that leukotriene 
Cd is an intermediate in leukotriene D4 biosynthesis 
as well as evidence for enzymatic conversion of leuko- 
triene & to C4 has been reported 112,261. 
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